Theophylline

Verify with FDA CVM →

172 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
172
Total Reports
35
Deaths Reported
2030.0%
Death Rate

Active Ingredients

Theophylline

Administration Routes

OralUnknown

Species Affected

Dog 164
Cat 8

Most Affected Breeds

Chihuahua 22
Maltese 10
Retriever - Labrador 10
Crossbred Canine/dog 9
Beagle 8
Spitz - German Pomeranian 7
Pug 7
Shepherd Dog - Australian 7
Terrier - Yorkshire 7
Dachshund (unspecified) 7

Most Reported Reactions

Vomiting 36
Lethargy (see also Central nervous system depression in 'Neurological') 29
Death by euthanasia 21
Cough 20
Decreased appetite 17
Other abnormal test result NOS 16
Abnormal radiograph finding 16
Diarrhoea 15
Emesis 15
Seizure NOS 14
Weight loss 13
Death 13

Outcome Breakdown

Recovered/Normal
50 (29.4%)
Ongoing
45 (26.5%)
Outcome Unknown
38 (22.4%)
Euthanized
21 (12.4%)
Died
14 (8.2%)
Recovered with Sequela
2 (1.2%)

Data Summary

Metric Value
Total adverse event reports 172
Reports involving death 35
Case-fatality rate (reported events) 2030.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Theophylline Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 172 adverse event reports referencing Theophylline, including 35 reports in which the animal died — a 2030.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Theophylline. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Theophylline reports are Dog (164 reports), Cat (8 reports), with Dog accounting for the largest share. Within those species, Chihuahua (22), Maltese (10), Retriever - Labrador (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Theophylline are Vomiting (36), Lethargy (see also Central nervous system depression in 'Neurological') (29), Death by euthanasia (21), Cough (20). Of the 170 reports with a coded outcome, Recovered/Normal is the leading category at 29.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Theophylline.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial